Selecting the Right Biologic for Your Patients With Severe Asthma

Annals of Allergy, Asthma and Immunology - United States
doi 10.1016/j.anai.2018.07.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biologic Therapy in Severe Asthma: An Update

Archives of Asthma, Allergy and Immunology
2019English

Algorithm for Selecting Ideal Biologic Treatment for Psoriasis

Journal of Clinical & Experimental Dermatology Research
2015English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

A Study of Patients With Severe Bronchial Asthma

The Journal of Kansai Medical University
1991English

Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Biologics in Severe Difficult-To-Treat Asthma: Find the Right Niche!

European Respiratory Review
PulmonaryRespiratory Medicine
2009English

The Right Solvent for Your Process.

Chemical and Engineering News
Chemical Engineering
1999English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

The Study of Severe Asthma in Latin America and Spain (1994-2004): Characteristics of Patients Hospitalized With Acute Severe Asthma

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy